Teen Immunization Education Sessions (TIES) On-Demand Learning

ODL_Chapter_ChildHealth-Logostieslogo small

**PLEASE REVIEW EACH SECTION PRIOR TO ACCESSING THE ACTIVITY.**

To access each section, click on the title to expand; to retract, click the title again.

 

Step 1 - Review Enduring CME Information

Teen Immunization Education Sessions (TIES) On-Demand Learning

This course is designed to provide resources for physicians to improve vaccination rates of adolescents in Ohio.

Target Audience: The target audience is pediatric healthcare providers, the majority of whom are general pediatricians and subspecialty pediatric physicians.

Objectives: Following completion of this educational activity, learners should be able to:

  1. Describe diseases prevented through adolescent immunization
  2. Review immunization schedules for adolescents
  3. Review issues related to vaccinating adolescents, such as strategies and safety
  4. Discuss TIES Best Practices

Needs Assessment/Gap:

The 2014 National Immunization Survey showed that several of the Ohio adolescent Immunization rates are low: Tdap: 83.0%; MenACWY: 73.7%; HPV for females: 1 shot 61.0%, 2 shots, 47.3%, 3 shots 35.2%; HPV for males: 36.8%, 29.3%, 23.3%. Aside from Tdap, for which Ohio has a school entry mandate, each vaccine is below the Healthy People 2020 goal of 80% adolescent vaccination to reduce preventable infectious diseases. The Human Papillomavirus (HPV) Vaccination Report for Ohio, compiled by the Centers for Disease Control and Prevention and distributed to states on a quarterly basis, reiterates that more efforts are needed to achieve the Health People 2020 HPV vaccination targets. The report shows there were no significant differences between 2013 and 2014 HPV vaccination rates.

A study released in October 2015 in the journal Pediatrics concluded increased efforts are needed to improve vaccination coverage, especially for those who are least likely to be vaccinated. This study focused on males and showed vaccination rates are very low in this population. In addition, a study published in October 2015 in the journal Cancer Epidemiology, Biomarkers & Prevention showed 27% of doctors surveyed said they do not strongly endorse HPV vaccination and 59% of doctors took a “risk-based” approach to the shots (only offering vaccination to teens they think are at higher risk for HPV), rather than vaccinating all of their pre-teen patients.

Accreditation Statement:

The Ohio Chapter, American Academy of Pediatrics (Ohio AAP) is accredited by the Ohio State Medical Association to provide continuing medical education for physicians. 

The Ohio AAP designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty List:

Robert W. Frenck, Jr., MD, FAAP
Interim Director and Medical Director of the Division of Infectious Diseases
Cincinnati Children’s Hospital Medical Center
Professor, UC Department of Pediatrics
Cincinnati, Ohio

Disclosure: It is the policy of the Ohio Chapter, American Academy of Pediatrics to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. This information is used to plan future activities.

The following faculty have no financial relationships other than listed above with commercial interests relevant to the content of this activity:

  • Robert W. Frenck, Jr., MD, FAAP

The CME staff, meeting planners, editorial staff, planning committee, and CME committee reviewers other than listed above do not have any relevant financial relationships to disclose.

Off-label Disclosure: This educational activity does not contain discussion of unlabeled and/or investigational uses of agents that are not approved by the FDA. Please consult the prescribing information for each product.

Medium & Education Instructions for Internet/On-Demand Learning:

Please allow for one hour to review the journal article, watch the video video and answer the questions.

Once you begin the assessment, you have until the end of the calendar year to complete it, but are not required to complete it in one sitting. You must answer all of the items AND answer 80% correctly in order to receive credit for this assessment.

Dates of original release, most recent review or update, and termination date:  

  • Release Date: November 16, 2015
  • Expiration Date: November 16, 2016

Commercial Support Acknowledgement: There is no financial support to acknowledge for this activity.

Step 2 - Review Activity Instructions


To visit the resources and slides associated with this activity, click here.

You will be asked to complete a Pre-Survey, review a journal article, watch the activity video, complete a Post-Survey and an evaluation.

Step 3 - Launch and Complete Assessment


Click here to begin the activity.

Please feel free to send any questions/comments/concerns to Sean O’Hanlon.